16α-Hydroxyprogesterone: Origin, biosynthesis and receptor interaction

Molecular and Cellular Endocrinology

Volumn 336, Issue 1-2, 2011, Pages 92-101

  Storbeck, Karl Heinz ^a   Swart, Pieter ^a   Africander, Donita ^a   Conradie, Riaan ^a   Louw, Renate ^a   Swart, Amanda C ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

16 Hydroxyprogesterone; 16 OHPROG; CYP17A1; Cytochrome P450 17 hydroxylase 17,20 lyase; PR; Progesterone receptor

Indexed keywords

16ALPHA HYDROXYPROGESTERONE; ALANINE; CYTOCHROME B5; CYTOCHROME P450 17; CYTOCHROME P450 17A1; PROGESTERONE RECEPTOR A; PROGESTERONE RECEPTOR B; UNCLASSIFIED DRUG;

ADRENAL CORTEX; AMINO ACID SEQUENCE; CATALYSIS; ENZYME ACTIVITY; ENZYME KINETICS; HORMONE RECEPTOR INTERACTION; HUMAN; NATRIURESIS; NONHUMAN; OVARY; PREGNANCY; PRIORITY JOURNAL; PROGESTERONE METABOLISM; PROGESTERONE SYNTHESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REPRODUCTION; REVIEW; STEROID HYDROXYLATION; TESTIS; TISSUE DISTRIBUTION;

BIOCATALYSIS; HUMANS; HYDROXYPROGESTERONES; RECEPTORS, PROGESTERONE; STEROID 17-ALPHA-HYDROXYLASE;

EID: 79952067546     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2010.11.016     Document Type: Review

References (90)

1. Arlt W., Martens J.W.M., Song M., Wang J.T., Auchus R.J., Miller W.L. Molecular evolution of adrenarche: structural and functional analysis of P450c17 from four primate species. Endocrinology 2002, 143:4665-4672.
2. Auchus R.J., Lee T.C., Miller W.L. Cytochrome b5 augments the 17,20-lyase activity of human P450c17 without direct electron transfer. J. Biol. Chem. 1998, 273:3158-3165.
3. Bamberger C.M., Bamberger A.M., de Castro M., Chrousos G.P. Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans. J. Clin. Invest. 1995, 95:2435-2441.
4. Bird C.E., Wiqvist N., Diczfalusy E., Solomon S. Metabolism of progesterone by the perfused previable human fetus. J. Clin. Endocrinol. Metab. 1966, 26:1144-1154.
5. Bloch E. Metabolism of 4-14C-progesterone by human fetal testis and ovaries. Endocrinology 1964, 74:833-845.
6. Calvin H.I., Lieberman S. Studies on the metabolism of 16α-hydroxyprogesterone in humans; conversion to urinary 17-isopregnanolone. Biochemistry 1962, 1:639-645.
7. Casey M.L., MacDonald P.C. Demonstration of steroid 17α-hydroxylase activity in human fetal kidney, thymus and spleen. Steroids 1982, 40:91-97.
8. Chatterton J.R., Forbes T.R. Relation of metabolites of progesterone to progesterone activity: 16α-hydroxyprogesterone antagonism in the uterine stromal nuclei of the mouse. Endocrinology 1973, 92:1451-1457.
9. Clarke C.L., Sutherland R.L. Progestin regulation of cellular proliferation. Endocr. Rev. 1990, 11:266-301.
10. Colla J.C., Liberti J.P., Ungar F. Inhibition of 16α-hydroxylation in human testis tissue by SU-9055. Steroids 1966, 8:25-32.
11. Conneely O.M., Mulac-Jericevic B., DeMayo F., Lydon J.P., O'Malley B.W. Reproductive functions of progesterone receptors. Recent Prog. Horm. Res. 2002, 57:339-355.
12. Den K., Haruyama T., Hagiwara H., Fujii K.T., Kambegawa A., Takami T., Yoshida T., Takagi S. Plasma levels of 16 alpha-hydroxypregnenolone, 16 alpha-hydroxyprogesterone and 16 alpha-hydroxydehydroepiandrosterone in the fetus and neonates. Endocrinol. Jpn. 1979, 26:439-447.
13. Forbes T.R., Taku E. 16alpha-hydroxy-progesterone as a sex hormone antagonist: effect on venous diameters in the female mouse. Anat. Rec. 1975, 182:67-70.
14. Geller D.H., Auchus R.J., Miller W.L. P450c17 mutations R347H and R358Q selectively disrupt 17,20-lyase activity by disrupting interactions with P450 oxidoreductase and cytochrome b5. Mol. Endocrinol. 1999, 13:167-175.
15. George J.M., Saucier G., Bartter F.C. Is there a potent, naturally occurring sodium-losing steroid hormone?. J. Clin. Endocrinol. Metab. 1965, 25:621-627.
16. Gotoh O. Substrate recognition sites in cytochrome P450 family 2 (CYP2). Proteins inferred from comparative analysis of amino acid and coding nucleotide sequences. J. Biol. Chem. 1992, 267:83-90.
17. Graham-Lorence S., Peterson J.A. P450s: structural similarities and functional differences. FASEB J. 1996, 10:206-214.
18. Griffiths K., Grant J.K., Whyte W.G. Steroid biosynthesis in vitro by cryptorchid testes from a case of testicular feminization. J. Clin. Endocrinol. Metab. 1963, 23:1044-1055.
19. Hakkola J., Pasanen M., Hukkanen J., Pelkonen O., Mäenpää J., Edwards R.J., Boobis A.R., Raunio H. Expression of xenobiotic-metabolizing cytochrome P450 forms in human full-term placenta. Biochem. Pharmacol. 1996, 51:403-411.
20. Hakkola J., Raunio H., Purkunen R., Pelkonen O., Saarikoski S., Cresteil T., Pasanen M. Detection of cytochrome P450 gene expression in human placenta in first trimester of pregnancy. Biochem. Pharmacol. 1996, 52:379-383.
21. Huang W.Y. Conversion of progesterone to 16-alpha-hydroxyprogesterone in normal human corpus luteum tissue. Steroids 1967, 10:107-114.
22. Hung Y.-C., Satyaswaroop P.G., Tabibzadeh S. The female reproductive system: cell lines from tumors of the human ovary and uterus. Atlas of Human Tumor Cell Lines 1994, 359-386. Academic Press, San Diego. R.J. Hay, J.-G. Park, A. Gazdar (Eds.).
23. Hyatt P.J., Bhatt K., Tait J.F. Steroid biosynthesis by zona fasciculata and zona reticularis cells purified from the mammalian adrenal cortex. J. Steroid Biochem. 1983, 19:953-959.
24. Inano H., Tamaoki B. In vitro effect of 16α-hydroxyprogesterone on the enzyme activities related to androgen production in human testes. Acta Endocrinol. 1978, 88:768-777.
25. Jacobs D.R. Natriuretic activity of 16α-hydroxyprogesterone in man. Acta Endocrinol. (Copenh.) 1969, 61:275-282.
26. Janoski A.H., Kelly W.G. On the metabolism of 16α-hydroxy-C21-steroids. II. Evidence for the presence of a glucuronide of 16α-hydroxypregnenolone in human urine and its utility in estimating the rates of production of 16α-hydroxyprogesterone and 16α-hydroxypregnenolone. J. Clin. Endocrinol. Metab. 1969, 29:1291-1300.
27. Janoski A.H., Roginsky M.S., Christy N.P., Kelly W.G. On the metabolism of 16α-hydroxy-C21-steroids. III. Evidence for high rates of production of 16α-hydroxyprogesterone and 16α-hydroxypregnenolone in the salt-losing form of congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 1969, 29:1301-1309.
28. Jungmann R.A., Schweppe J.S. Biosynthesis and metabolism of neutral steroids by human midterm placenta and fetal liver. J. Clin. Endocrinol. Metab. 1967, 27:1151-1160.
29. Kastner P., Bocquel M.T., Turcotte B., Garnier J.M., Horwitz K.B., Chambon P., Gronemeyer H. Transient expression of human and chicken progesterone receptors does not support alternative translational initiation from a single mRNA as the mechanism generating two receptor isoforms. J. Biol. Chem. 1990, 265:12163-12167.
30. Katagiri M., Kagawa N., Waterman M.R. The role of cytochrome b5 in the biosynthesis of androgens by human P450c17. Arch. Biochem. Biophys. 1995, 317:343-347.
31. Kayes-Wandover K.M., White P.C. Steroidogenic enzyme gene expression in the human heart. J. Clin. Endocrinol. Metab. 2000, 85:2519-2525.
32. Kojima S., Yanaihara T., Nakayama T. Serum steroid levels in children at birth and in early neonatal period. Am. J. Obstet. Gynecol. 1981, 15:961-965.
33. Lanman J.T. The adrenal gland in the human fetus. Pediatrics 1961, 27:140-158.
34. Lin D., Black S.M., Nagahama Y., Miller W.L. Steroid 17α-hydroxylase and 17,20-lyase activities of P45Oc17: contributions of serine106 and P450 reductase. Endocrinology 1993, 132:2498-2506.
35. Lisboa B.P., Gustafsson J. Biosynthesis of 16α-hydroxyprogesterone by human fetal liver microsomes. Steroids 1968, 12:248-260.
36. Little B., Shaw A., Purdy R. The conversion of progesterone to 16α-hydroxy-pregn-4-ene-3,20-dione and androst-4-ene-3,17-dione by human placenta in vitro. Acta Endocrinol. (Copenh.) 1963, 43:510-520.
37. Lorence M.C., Trant J.M., Clark B.J., Khyatt B., Mason J.I., Estabrook R.W., Waterman M.R. Construction and expression of human/bovine P45017, chimeric proteins: evidence for distinct tertiary structures in the same P450 from two different species. Biochemistry 1990, 29:9819-9824.
38. Mangal R.K., Wiehle R.D., Poindexter A.N., Weigel N.L. Differential expression of uterine progesterone receptor forms A and B during the menstrual cycle. J. Steroid Biochem. Mol. Biol. 1997, 63:195-202.
39. Maruyama S., Suzuki T., Yanaihara T., Araki H., Nakayawa T. C21-steroid profiles in pregnancy associated with intrauterine growth retardation. Nippon Sanka Fujinka Gakkai Zasshi 1986, 38:513-519.
40. Mesiano S., Coulter C.L., Jaffe R.B. Localization of cytochrome P450 cholesterol side-chain cleavage, cytochrome P450 17α-hydroxylase/17,20-lyase, and 3β-hydroxysteroid dehydrogenase isomerase steroidogenic enzymes in human and rhesus monkey fetal adrenal glands: reappraisal of functional zonation. J. Clin. Endocrinol. Metab. 1993, 77:1184-1189.
41. Miller W.L. Steroid hormone biosynthesis and actions in the materno-feto-placental unit. Clin. Perinatol. 1998, 25:799-817.
42. Moles C.G., Mendes P., Banga J.R. Parameter estimation in biochemical pathways: a comparison of global optimization methods. Genome Res. 2003, 13:2467-2474.
43. Moran F.M., Van de Voort C.A., Overstreet J.W., Lasley B.L., Conley A.J. Molecular target of endocrine disruption in human luteinizing granulosa cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin: inhibition of estradiol secretion due to decreased 17α-hydroxylase/17,20-lyase cytochrome P450 expression. Endocrinology 2003, 144:467-473.
44. Nakajin S., Hall P.F. Microsomal cytochrome P-450 from neonatal pig testis. Purification and properties of A C21 steroid side chain cleavage system (17α-hydroxylase-C17,20 lyase). J. Biol. Chem. 1981, 256:3871-3876.
45. Nakajin S., Shively J.E., Yuan P., Hall P.F. Microsomal cytochrome P450 from neonatal pig testis: two enzymatic activities (17α-hydroxylase and C17,20-lyase) associated with one protein. Biochemistry 1981, 20:4037-4042.
46. Narasaka T., Suzuki T., Moriya T., Sasano H. Temporal and spatial distribution of corticosteroidogenic enzymes immunoreactivity in developing human adrenal. Mol. Cell. Endocrinol. 2001, 174:111-120.
47. Niwa T., Yabusakioe Y., Honma K., Matsuo N., Tatsuta K., Ishibashi F., Katagiri M. Contribution of human hepatic cytochrome P450 isoforms to regioselective hydroxylation of steroid hormones. Xenobiotica 1998, 28:539-547.
48. Ogawa K., Hirato K., Suzuki T., Saitoh H., Yanaihara T., Nakayama T. Steroid levels and myometrial sensitivity to oxytocin. Nippon Sanka Fujinka Gakkai Zasshi 1984, 36:1203-1212.
49. Oshima H., Sarada T., Ochi-Ai K., Tamaoki B. Intracellular distribution and properties of steroid 16α-hydroxylase in human testes. J. Clin. Endocrinol. Metab. 1967, 27:1249-1254.
50. Puche C.M., Jose M., Cabero A., Meseguer A. Expression and enzymatic activity of the P450c17 gene in human adipose tissue. Eur. J. Endocrinol. 2002, 146:223-229.
51. Quinkler M., Meyer B., Bumke-Vogt C., Grossmann C., Gruber U., Oelkers W., Diederich S., Bahr V. Agonistic and antagonistic properties of progesterone metabolites at the human mineralocorticoid receptor. Eur. J. Endocrinol. 2002, 146:789-799.
52. Quinkler M., Bumke-Vogt C., Meyer B., Bähr V., Oelkers W., Diederich S. The human kidney is a progesterone-metabolizing and androgen-producing organ. J. Clin. Endocrinol. Metab. 2003, 88:2803-2809.
53. Ramseyer J., Zala A.P., Levy R.P., Linton D.S., Hirschmann H. Secretion of 16α-hydroxyprogesterone and other steroids by the adult human adrenal. J. Clin. Endocrinol. Metab. 1974, 39:102-107.
54. Reynolds J.W., Wiqvist N., Diczfalusy E. Metabolism of 16α-hydroxy-pregnenolone and 17α-hydroxypregnenolone in the foetoplacental unit and mother at midgestation. Acta Endocrinol. (Copenh.) 1969, 61:533-550.
55. Rheaume E., Lachance Y., Zhao H.F., Breton N., Dumont M., de Launoit Y., Trudel C., Luu-The V., Simard J., Labrie F. Structure and expression of a new complementary DNA encoding the almost exclusive 3β-hydroxysteroid dehydrogenase/Δ5-Δ4-isomerase in human adrenals and gonads. Mol. Endocrinol. 1991, 5:1147-1157.
56. Richer J.K., Jacobsen B.M., Manning N.G., Abel M.G., Wolf D.M., Horwitz K.B. Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells. J. Biol. Chem. 2002, 277:5209-5218.
57. Ruse J.L., Solomon S. The isolation and origin of urinary 16α-hydroxyprogesterone. Biochemistry 1966, 5:1072-1079.
58. Saez J.M. Leydig cells: endocrine, paracrine, and autocrine regulation. Endocr. Rev. 1994, 15:574-626.
59. Sano Y., Suzuki K., Arai K., Okinaga S., Tamaoki B. Changes in enzyme activities related to steroidogenesis in human ovaries during the menstrual cycle. J. Clin. Endocrinol. Metab. 1981, 52:994-1001.
60. Sasano H., Okamoto M., Mason J.I., Simpson E.R., Mendelson C.R., Sasano N., Silverberg S.G. Immunolocalization of aromatase, 17α-hydroxylase and side-chain-cleavage cytochromes P-450 in the human ovary. J. Reprod. Fertil. 1989, 85:163-169.
61. Schwarz D., Kisselev P., Schunck W., Chernogolov A., Boidol W., Cascorbi I., Roots I. Allelic variants of human cytochrome P450 1A1 (CYP1A1): effect of T461N and I462V substitutions on steroid hydroxylase specificity. Pharmacogenetics 2000, 10:519-530.
62. Sharma D.C., Dorfman R.I., Southren A.L. Steroid biosynthesis in vitro by feminizing testes. Endocrinology 1965, 76:966-978.
63. Shibusawa H., Sano Y., Yamamoto T., Kambegawa A., Ohkawa T., Satoh N., Okinaga S., Arai K. A radioimmunoassay of serum 16alpha-hydroxypregnenolone with specific antiserum. Endocrinol. Jpn. 1978, 25:185-189.
64. Shyamala G., Schneider W., Schott D. Developmental regulation of murine mammary progesterone receptor gene expression. Endocrinology 1990, 126:2882-2889.
65. Simard J., Durocher F., Mebarki F., Turgeon C., Sanchez R., Labrie Y., Couet J., Trudel C., Rheaume E., Morel Y., Luu-The V., Labrie F. Molecular biology and genetics of the 3β-hydroxysteroid dehydrogenase/Δ5-Δ4 isomerase gene family. J. Endocrinol. 1996, 150(Suppl.):S189-S207.
66. Smid-Koopman E., Blok L.J., Kühne L.C., Burger C.W., Helmerhorst T.J., Brinkmann A.O., Huikeshoven F.J. Distinct functional differences of human progesterone receptors A and B on gene expression and growth regulation in two endometrial carcinoma cell lines. J. Soc. Gynecol. Investig. 2003, 10:49-57.
67. Soyal S.M., Mukherjee A., Lee K.Y., Li J., Li H., DeMayo F.J., Lydon J.P. Cre-mediated recombination in cell lineages that express the progesterone receptor. Genesis 2005, 41:58-66.
68. Stiefel M., Ruse J.L. Urinary excretion of 16α-hydroxyprogesterone during pregnancy and the menstrual cycle. J. Clin. Endocrinol. Metab. 1969, 29:919-925.
69. Storbeck K., Swart A.C., Slabbert J.T., Swart P. The identification of two CYP17A1 alleles in the South African Angora Goat. Drug Metab. Rev. 2007, 39:467-480.
70. Storbeck K., Kolar M.W., Stander M., Prevoo D., Swart A.C., Swart P. The development of an UPLC-coupled atmospheric pressure chemical ionization mass spectrometry assay for seven adrenal steroids. Anal. Biochem. 2008, 372:11-20.
71. Swart A.C., Kolar N.W., Lombard N., Mason J.I., Swart P. Baboon cytochrome P450 17alpha-hydroxylase/17,20-lyase (CYP17A1): characterisation of the adrenal microsomal and cloned enzymes. Eur. J. Biochem. 2002, 269:5608-5616.
72. Swart A.C., Storbeck K., Swart P. A single amino acid residue, Ala 105, confers 16α-hydroxylase activity to human cytochrome P450 17α-hydroxylase/17,20 lyase. J. Steroid Biochem. Mol. Biol. 2010, 119:112-120.
73. Swart P., Swart A.C., Waterman W.L., Estabrook R.W., Mason J.I. Progesterone 16α-hydroxylase activity is catalyzed by human cytochrome P450 17α-hydroxylase. J. Clin. Endocrinol. Metab. 1993, 771:98-102.
74. Turgeon J.L., McDonnell D.P., Martin K.A., Wise P.M. Hormone therapy: physiological complexity belies therapeutic simplicity. Science (New York, N.Y.). 2004, 304:1269-1273.
75. Uete T., Venning E.H. Effects of 16α-OH-Δ4- and Δ5-pregnene compounds with respect to electrolyte excretion of aldosterone. Endocrinology 1963, 72:397-402.
76. Villee D.B., Engel L.L., Loring J.M., Villee C.A. Steroid hydroxylation in human fetal adrenals: formation of 16α-hydroxyprogesterone, 17-hydroxyprogesterone and deoxycorticosterone. Endocrinology 1961, 69:354-372.
77. Villee D.B., Dimoline A., Engel L.L., Villee C.A., Raker J. Formation of 16α-hydroxyprogesterone in hyperplastic adrenal tissue. J. Clin. Endocrinol. Metab. 1962, 22:726-734.
78. Villee D.B. Effects of substrates and cofactors on steroid synthesis in hyperplastic adrenals. J. Clin. Endocrinol. Metab. 1964, 24:442-455.
79. Villee D.B., Driscoll S.G. Pregnenolone and progesterone metabolism in human adrenals from twin female fetuses. Endocrinology 1965, 77:602-608.
80. Viscelli T.A., Hudson P.B., Lombardo M.E. The conversion of progesterone to 16α-hydroxypregn-4-en-3,20-dione by the normal human testis in vitro. Steroids 1965, 5:545-550.
81. Ward P.J., Grant J.K. The metabolism of [4-14C]-progesterone by adrenocortical tissue from patients with Cushing's syndrome. J. Endocrinol. 1963, 26:139-147.
82. Warren J.C., Salhanick H.A. Demonstration of 16alpha-hydroxylase in the human ovary. J. Clin. Endocrinol. Metab. 1961, 21:1376-1383.
83. Waxman D.J., Attisano C., Guengerich F.P., Lapenson D.P. Human liver microsomal steroid metabolism: identification of the major microsomal steroid hormone 6β-hydroxylase cytochrome P-450 enzyme. Arch. Biochem. Biophys. 1988, 263:424-436.
84. Waxman D.J., Lapenson D.P., Aoyama T., Gelboin H.V., Gonzalez F.J., Korzekwa K. Steroid hormone hydroxylase specificities of eleven cDNA-expressed human cytochrome P450s. Arch. Biochem. Biophys. 1991, 290:160-166.
85. Wilson R., Bird C., Wiqvist N., Solomon S., Diczfalusy E. Metabolism of progesterone by the perfused adrenalectomized human fetus. J. Clin. Endocrinol. Metab. 1966, 26:1155-1159.
86. Yamazaki H., Shimada T. Progesterone and testosterone hydroxylation by cytochromes P450 2C19, 2C9, and 3A4 in human liver microsomes. Arch. Biochem. Biophys. 1997, 346:161-169.
87. Zander J., Thijssen J., von Münstermann A. Isolation and identification of 16alpha-hydroxyprogesterone from human corpora lutea and placental blood. J. Clin. Endocrinol. Metab. 1962, 22:861-862.
88. Zander J., von Münstermann A., Runnebaum B. Steroids in the plasma of human placental blood (cord blood). Acta Endocrinol. (Copenh.) 1962, 41:507-520.
89. Zander J. Hormone synthesis by the placenta and its significance for the fetus. Arch Gynakol. 1963, 198:113-127.
90. Zhao Q., Pang J., Favata M.F., Trzaskos J.M. Receptor density dictates the behavior of a subset of steroid ligands in glucocorticoid receptor-mediated transrepression. Int. Immunopharmacol. 2003, 3:1803-1817.